Cancer stem cells and field cancerization of Oral squamous cell carcinoma

Oral Oncology

Volumn 51, Issue 7, 2015, Pages 643-651

  Simple, M ^a,b   Suresh, Amritha ^a,c   Das, Debashish ^d   Kuriakose, Moni A ^a,c  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b VIT UNIVERSITY   (India)

^c Mazumdar Shaw Center for Translational Research ^*  (India)

^d the Department of Uveitis and Ocular Immunology   (India)

Author keywords

Cancer stem cells; Field cancerization; Loss of heterozygosity; Migration; Oral carcinogenesis; Oral squamous cell carcinoma; Recurrent tumor; Second primary tumor

Indexed keywords

ANGIOGENIC FACTOR; CARCINOGEN; CELL MARKER; CYCLIN D1; CYTOKERATIN 18; CYTOKERATIN 19; EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN; MOLECULAR MARKER; TELOMERASE; TUMOR MARKER; UVOMORULIN;

ANGIOGENESIS; CANCER RECURRENCE; CANCER STEM CELL; CARCINOGENESIS; CELL DEDIFFERENTIATION; CELL MIGRATION; CELL POPULATION; CELL RENEWAL; EPITHELIAL MESENCHYMAL TRANSITION; HETEROZYGOSITY LOSS; HUMAN; METASTASIS; MOUTH MUCOSA; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; REVIEW; SECOND CANCER; CELL TRANSFORMATION; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; NEOPLASTIC STEM CELLS;

EID: 84931575394     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2015.04.006     Document Type: Review

References (104)

1. B.J. Braakhuis, C.R. Leemans, and R.H. Brakenhoff Expanding fields of genetically altered cells in head and neck squamous carcinogenesis Semin Cancer Biol. 15 2005 113 120
2. A. Kyrgidis, K. Vahtsevanos, T.G. Tzellos, P. Xirou, K. Kitikidou, and K. Antoniades Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital Euro J Dermatol EJD 20 2010 276 282
3. R.D.O.P. Farhadieh, K. Taghavi, A. Salardini, P. Russell, and R. Smee Second primary tumours of the head and neck are not associated with adverse overall survival in oral squamous cell carcinomas J Cancer Sci Ther 2011 p. 030-4
4. L.L. Feller, R.R. Khammissa, B.B. Kramer, and J.J. Lemmer Oral squamous cell carcinoma in relation to field precancerisation: pathobiology Cancer Cell Int 13 2013 31
5. I. Triviai, T. Stubig, B. Niebuhr, K. Hussein, A. Tsiftsoglou, and B. Fehse CD133 marks a stem cell population that drives human Primary Myelofibrosis Haematologica 2015
6. Y. Bu, and D. Cao The origin of cancer stem cells Front Biosci 4 2012 819 830
7. G. Sun, M. Fujii, A. Sonoda, Y. Tokumaru, T. Matsunaga, and N. Habu Identification of stem-like cells in head and neck cancer cell lines Anticancer Res 30 2010 2005 2010
8. S.H. Chiou, C.C. Yu, C.Y. Huang, S.C. Lin, C.J. Liu, and T.H. Tsai Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma Clin Cancer Res: An Official J Am Assoc Cancer Res 14 2008 4085 4095
9. X. Zhou, G.R. Huang, and P. Hu Over-expression of Oct4 in human esophageal squamous cell carcinoma Mol Cells 32 2011 39 45
10. F. Bhaijee, D.J. Pepper, K.T. Pitman, and D. Bell Cancer stem cells in head and neck squamous cell carcinoma: a review of current knowledge and future applications Head Neck 34 2012 894 899
11. A. Alt-Holland, Y. Shamis, K.N. Riley, T.M. DesRochers, N.E. Fusenig, and I.M. Herman E-cadherin suppression directs cytoskeletal rearrangement and intraepithelial tumor cell migration in 3D human skin equivalents J Invest Dermatol 128 2008 2498 2507
12. L.L. Tsai, F.W. Hu, S.S. Lee, C.H. Yu, C.C. Yu, and Y.C. Chang Oct4 mediates tumor initiating properties in oral squamous cell carcinomas through the regulation of epithelial-mesenchymal transition PLoS One 9 2014 e87207
13. T. Masui, I. Ota, J.I. Yook, S. Mikami, K. Yane, and T. Yamanaka Snail-induced epithelial-mesenchymal transition promotes cancer stem cell-like phenotype in head and neck cancer cells Int J Oncol 44 2014 693 699
14. A. Biddle, X. Liang, L. Gammon, B. Fazil, L.J. Harper, and H. Emich Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative Cancer Res 71 2011 5317 5326
15. C. Bianchini, A. Ciorba, S. Pelucchi, R. Piva, and A. Pastore Targeted therapy in head and neck cancer Tumori 97 2011 137 141
16. D.P. Slaughter, H.W. Southwick, and W. Smejkal Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin Cancer 6 1953 963 968
17. M.G. van Oijen, and P.J. Slootweg Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits? Cancer Epidemiol Biomarkers Prev 9 2000 249 256
18. P.V. Angadi, J.K. Savitha, S.S. Rao, and Y. Sivaranjini Oral field cancerization: current evidence and future perspectives Oral Maxillofac Surg 16 2012 171 180
19. B.J. Braakhuis, M.P. Tabor, J.A. Kummer, C.R. Leemans, and R.H. Brakenhoff A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications Cancer Res 63 2003 1727 1730
20. J. Califano, P. van der Riet, W. Westra, H. Nawroz, G. Clayman, and S. Piantadosi Genetic progression model for head and neck cancer: implications for field cancerization Cancer Res 56 1996 2488 2492
21. R. Cabanillas, and J.L. Llorente The stem cell network model: clinical implications in cancer Eur Arch Otorhinolaryngol 266 2009 161 170
22. Z.T. Zhou, and W.W. Jiang Cancer stem cell model in oral squamous cell carcinoma Curr Stem Cell Res Ther 3 2008 17 20
23. R. Bjerkvig, B.B. Tysnes, K.S. Aboody, J. Najbauer, and A.J. Terzis Opinion: the origin of the cancer stem cell: current controversies and new insights Nat Rev Cancer 5 2005 899 904
24. M.A. Gonzalez-Moles, C. Scully, I. Ruiz-Avila, and J.J. Plaza-Campillo The cancer stem cell hypothesis applied to oral carcinoma Oral Oncol 49 2013 738 746
25. M. Herreros-Villanueva, J.S. Zhang, A. Koenig, E.V. Abel, T.C. Smyrk, and W.R. Bamlet SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells Oncogenesis 2 2013 e61
26. S.M. Kumar, S. Liu, H. Lu, H. Zhang, P.J. Zhang, and P.A. Gimotty Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation Oncogene 31 2012 4898 4911
27. J.H. Moon, S. Kwon, E.K. Jun, A. Kim, K.Y. Whang, and H. Kim Nanog-induced dedifferentiation of p53-deficient mouse astrocytes into brain cancer stem-like cells Biochem Biophys Res Commun 412 2011 175 181
28. R. Di Fiore, M. Marcatti, R. Drago-Ferrante, A. D'Anneo, M. Giuliano, and D. Carlisi Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells Bone 60 2014 198 212
29. H. Land, L.F. Parada, and R.A. Weinberg Cellular oncogenes and multistep carcinogenesis Science 222 1983 771 778
30. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
31. C.B.K. Squier Human oral mucosa: development, structure and function 2011 Wiley-Blackwell
32. M. Smalley, and A. Ashworth Stem cells and breast cancer: A field in transit Nat Rev Cancer 3 2003 832 844
33. C.C. Yu, and Y.C. Chang Enhancement of cancer stem-like and epithelial-mesenchymal transdifferentiation property in oral epithelial cells with long-term nicotine exposure: reversal by targeting SNAIL Toxicol Appl Pharmacol 266 2013 459 469
34. B. Qiao, B. He, J. Cai, and W. Yang The expression profile of Oct4 and Sox2 in the carcinogenesis of oral mucosa Int J Clin Exp Pathol 7 2014 28 37
35. N. Agrawal, M.J. Frederick, C.R. Pickering, C. Bettegowda, K. Chang, and R.J. Li Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 Science 333 2011 1154 1157
36. J. Chen, S. Kesari, C. Rooney, P.R. Strack, J. Chen, and H. Shen Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres Genes Cancer 1 2010 822 835
37. V. Catalano, A. Turdo, S. Di Franco, F. Dieli, M. Todaro, and G. Stassi Tumor and its microenvironment: a synergistic interplay Semin Cancer Biol 23 2013 522 532
38. B. Hu, E. Castillo, L. Harewood, P. Ostano, A. Reymond, and R. Dummer Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling Cell 149 2012 1207 1220
39. Z. Zhang, Z. Dong, I.S. Lauxen, M.S. Filho, and J.E. Nor Endothelial cell-secreted EGF induces epithelial to mesenchymal transition and endows head and neck cancer cells with stem-like phenotype Cancer Res 74 2014 2869 2881
40. A. Suresh, M. Vannan, D. Kumaran, Z.H. Gumus, P. Sivadas, and E.E. Murugaian Resistance/response molecular signature for oral tongue squamous cell carcinoma Dis Markers 32 2012 51 64
41. E. Gallmeier, P.C. Hermann, M.T. Mueller, J.G. Machado, A. Ziesch, and E.N. De Toni Inhibition of ataxia telangiectasia- and Rad3-related function abrogates the in vitro and in vivo tumorigenicity of human colon cancer cells through depletion of the CD133(+) tumor-initiating cell fraction Stem Cells 29 2011 418 429
42. S.A. McDonald, L.C. Greaves, L. Gutierrez-Gonzalez, M. Rodriguez-Justo, M. Deheragoda, and S.J. Leedham Mechanisms of field cancerization in the human stomach: the expansion and spread of mutated gastric stem cells Gastroenterology 134 2008 500 510
43. S.B. Garcia, H.S. Park, M. Novelli, and N.A. Wright Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets J Pathol 187 1999 61 81
44. M.S. Mulvihill, J.R. Kratz, P. Pham, D.M. Jablons, and B. He The role of stem cells in airway repair: implications for the origins of lung cancer Chin J Cancer 32 2013 71 74
45. R.L. Atkinson, W.T. Yang, D.G. Rosen, M.D. Landis, H. Wong, and M.T. Lewis Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency Breast Cancer Res 15 2013 R77
46. M.L. Agius Distinctive parameters of action of stem cells and modulatory microenvironmental microcirculation in gliomagenesis. Stem Cell Discovery 3 2013 1 6
47. X. Xu, X. Zhang, S. Wang, H. Qian, W. Zhu, and H. Cao Isolation and comparison of mesenchymal stem-like cells from human gastric cancer and adjacent non-cancerous tissues J Cancer Res Clin Oncol 137 2011 495 504
48. D.C. Yu, J. Chen, X.T. Sun, L.Y. Zhuang, C.P. Jiang, and Y.T. Ding Mechanism of endothelial progenitor cell recruitment into neo-vessels in adjacent non-tumor tissues in hepatocellular carcinoma BMC Cancer 10 2010 435
49. B.J. Braakhuis, M.P. Tabor, C.R. Leemans, I. van der Waal, G.B. Snow, and R.H. Brakenhoff Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions Head Neck 24 2002 198 206
50. M.P. Tabor, R.H. Brakenhoff, H.J. Ruijter-Schippers, J.E. Van Der Wal, G.B. Snow, and C.R. Leemans Multiple head and neck tumors frequently originate from a single preneoplastic lesion Am J Pathol 161 2002 1051 1060
51. R.J. Shaw, A.J. Hobkirk, G. Nikolaidis, J.A. Woolgar, A. Triantafyllou, and J.S. Brown Molecular staging of surgical margins in oral squamous cell carcinoma using promoter methylation of p16(INK4A), cytoglobin, E-cadherin, and TMEFF2 Ann Surg Oncol 20 2013 2796 2802
52. M. Di Domenico, A. Santoro, C. Ricciardi, M. Iaccarino, S. Iaccarino, and M. Freda Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization Cancer Biol Ther 12 2011 447 457
53. Y. Arima, N. Hayashi, H. Hayashi, M. Sasaki, K. Kai, and E. Sugihara Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor-negative breast cancer Int J Cancer 130 2012 2568 2579
54. O. Martinez-Iglesias, S. Garcia-Silva, S.P. Tenbaum, J. Regadera, F. Larcher, and J.M. Paramio Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis Cancer Res 69 2009 501 509
55. C.M. Croce, G. Sozzi, and K. Huebner Role of FHIT in human cancer J Clin Oncol 17 1999 1618 1624
56. U.R. Peters, U. Hasse, E. Oppliger, M. Tschan, S.T. Ong, and F.V. Rassool Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemia Oncogene 18 1999 79 85
57. L.Y. Fong, V. Fidanza, N. Zanesi, L.F. Lock, L.D. Siracusa, and R. Mancini Muir-Torre-like syndrome in Fhit-deficient mice Proc Natl Acad Sci U S A 97 2000 4742 4747
58. C.C. Khor, S. Davila, C. Shimizu, S. Sheng, T. Matsubara, and Y. Suzuki Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease J Med Genet 48 2011 467 472
59. S. Warrier, P. Pavanram, D. Raina, and M. Arvind Study of chemoresistant CD133+ cancer stem cells from human glioblastoma cell line U138MG using multiple assays Cell Biol Int 36 2012 1137 1143
60. R.A. Weinberg The retinoblastoma gene and gene product Cancer Surv 12 1992 43 57
61. A. Lasorella, G. Rothschild, Y. Yokota, R.G. Russell, and A. Iavarone Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice Mol Cell Biol 25 2005 3563 3574
62. C. Takahashi, N. Sasaki, and S. Kitajima Twists in views on RB functions in cellular signaling, metabolism and stem cells Cancer Sci 103 2012 1182 1188
63. J. Sage The retinoblastoma tumor suppressor and stem cell biology Genes Dev 26 2012 1409 1420
64. H. Blons, and P. Laurent-Puig TP53 and head and neck neoplasms Hum Mutat 21 2003 252 257
65. N. Agrawal, J. Califano, and P. Ha Molecular biology of head and neck cancers V.T. DeVita Jr. T.S. Lawrence, S.A. Rosenberg, R.A. DePinho, R.A. Weinberg, DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology 9th ed. 2011 Lippincott Williams & Wilkins, a Wolter Kluwer business Philadelphia, USA 723 727
66. E. Campo, O. de la Calle-Martin, R. Miquel, A. Palacin, M. Romero, and V. Fabregat Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas Cancer Res 51 1991 4436 4442
67. J. Einspahr, D.S. Alberts, M. Aickin, K. Welch, P. Bozzo, and T. Grogan Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin Cancer Epidemiol Biomarkers Prev 6 1997 583 587
68. V. Bongers, G.B. Snow, I. van der Waal, and B.J. Braakhuis Value of p53 expression in oral cancer and adjacent normal mucosa in relation to the occurrence of multiple primary carcinomas Eur J Cancer B Oral Oncol 31B 1995 392 395
69. S. Godar, T.A. Ince, G.W. Bell, D. Feldser, J.L. Donaher, and J. Bergh Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression Cell 134 2008 62 73
70. M. Zhang, F. Behbod, R.L. Atkinson, M.D. Landis, F. Kittrell, and D. Edwards Identification of tumor-initiating cells in a p53-null mouse model of breast cancer Cancer Res 68 2008 4674 4682
71. Y. Yajima, H. Noma, Y. Furuya, T. Nomura, T. Yamauchi, and K. Kasahara Quantification of telomerase activity of regions unstained with iodine solution that surround oral squamous cell carcinoma Oral Oncol 40 2004 314 320
72. C. Mehle, A. Lindblom, B. Ljungberg, R. Stenling, and G. Roos Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma Int J Oncol 13 1998 289 295
73. K.A. Trujillo, W.C. Hines, K.M. Vargas, A.C. Jones, N.E. Joste, and M. Bisoffi Breast field cancerization: isolation and comparison of telomerase-expressing cells in tumor and tumor adjacent, histologically normal breast tissue Mol Cancer Res 9 2011 1209 1221
74. I. Joseph, R. Tressler, E. Bassett, C. Harley, C.M. Buseman, and P. Pattamatta The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines Cancer Res 70 2010 9494 9504
75. J.W. Shay, and W.E. Wright Telomeres and telomerase in normal and cancer stem cells FEBS Lett 584 2010 3819 3825
76. K.A. Trujillo, C.M. Heaphy, M. Mai, K.M. Vargas, A.C. Jones, and P. Vo Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumors Int J Cancer 129 2011 1310 1321
77. J.F. Lo, C.C. Yu, S.H. Chiou, C.Y. Huang, C.I. Jan, and S.C. Lin The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers Cancer Res 71 2011 1912 1923
78. K.B. Heiden, A.J. Williamson, M.E. Doscas, J. Ye, Y. Wang, and D. Liu The sonic hedgehog signaling pathway maintains the cancer stem cell self-renewal of anaplastic thyroid cancer by inducing Snail expression J Clin Endocrinol Metabol 2014 jc20141844
79. M. Roesch-Ely, A. Leipold, M. Nees, D. Holzinger, A. Dietz, and C. Flechtenmacher Proteomic analysis of field cancerization in pharynx and oesophagus: a prospective pilot study J Pathol 221 2010 462 470
80. L. Duan, R. Wu, L. Ye, H. Wang, X. Yang, and Y. Zhang S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/beta-catenin pathway PloS one 8 2013 e62092
81. C.N. Tseng, C.F. Huang, C.L. Cho, H.W. Chang, C.W. Huang, and C.C. Chiu Brefeldin a effectively inhibits cancer stem cell-like properties and MMP-9 activity in human colorectal cancer colo 205 cells Molecules 18 2013 10242 10253
82. D.R. Mane, A.D. Kale, P. Angadi, and S. Hallikerimath Expression of cytokeratin subtypes: MMP-9, p53, and alphaSMA to differentiate basaloid squamous cell carcinoma from other basaloid tumors of the oral cavity Appl Immunohistochem Mol Morphol 21 2013 431 443
83. A. Dittmer, K. Hohlfeld, J. Lutzkendorf, L.P. Muller, and J. Dittmer Human mesenchymal stem cells induce E-cadherin degradation in breast carcinoma spheroids by activating ADAM10 Cell Mol Life Sci 66 2009 3053 3065
84. A. Calvo, R. Catena, M.S. Noble, D. Carbott, I. Gil-Bazo, and O. Gonzalez-Moreno Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis Oncogene 27 2008 5373 5384
85. C.G. Bredin, Z. Liu, and J. Klominek Growth factor-enhanced expression and activity of matrix metalloproteases in human non-small cell lung cancer cell lines Anticancer Res 23 2003 4877 4884
86. R. El-Gazzar, M. Macluskey, and G.R. Ogden Evidence for a field change effect based on angiogenesis in the oral mucosa? A brief report Oral Oncol 41 2005 25 30
87. A. Fantozzi, D.C. Gruber, L. Pisarsky, C. Heck, A. Kunita, and M. Yilmaz VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation Cancer Res 74 2014 1566 1575
88. A.D. Kale, D.R. Mane, D. Babji, and K. Gupta Establishment of field change by expression of cytokeratins 8/18, 19, and MMP-9 in an apparently normal oral mucosa adjacent to squamous cell carcinoma: a immunohistochemical study J Oral Maxillofac Pathol 16 2012 10 15
89. Y. Wang, J.F. Zhu, Y.Y. Liu, and G.P. Han An analysis of cyclin D1, cytokeratin 5/6 and cytokeratin 8/18 expression in breast papillomas and papillary carcinomas Diagn Pathol 8 2013 8
90. S. Kalyankrishna, and J.R. Grandis Epidermal growth factor receptor biology in head and neck cancer J Clin Oncol 24 2006 2666 2672
91. O. Abbas, J.E. Richards, R. Yaar, and M. Mahalingam Stem cell markers (cytokeratin 15, cytokeratin 19 and p63) in in situ and invasive cutaneous epithelial lesions Modern Pathol: Official J United States and Canad Acad Pathology, Inc 24 2011 90 97
92. D.R. Emlet, P. Gupta, M. Holgado-Madruga, C.A. Del Vecchio, S.S. Mitra, and S.Y. Han Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III Cancer Res 74 2014 1238 1249
93. J. Jiao, L. Huang, F. Ye, M. Shi, X. Cheng, and X. Wang Cyclin D1 affects epithelial-mesenchymal transition in epithelial ovarian cancer stem cell-like cells Onco Targets Ther 6 2013 667 677
94. P. Keohavong, H.H. Mady, W.M. Gao, J.M. Siegfried, J.D. Luketich, and M.F. Melhem Topographic analysis of K- ras mutations in histologically normal lung tissues and tumours of lung cancer patients Brit J Cancer 85 2001 235 241
95. B.S. Moon, W.J. Jeong, J. Park, T.I. Kim, S. Min do, and K.Y. Choi Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/beta-catenin signaling J Natl Cancer Inst 106 2014 djt373
96. M.A. Gonzalez-Moles, C. Scully, and I. Ruiz-Avila Molecular findings in oral premalignant fields: update on their diagnostic and clinical implications Oral Dis 18 2012 40 47
97. T. Bleul, R. Ruhl, S. Bulashevska, S. Karakhanova, J. Werner, and A.V. Bazhin Reduced retinoids and retinoid receptors' expression in pancreatic cancer: a link to patient survival Mol Carcinogenesis 2014
98. S.C. Li, L.T. Vu, H.W. Ho, H.Z. Yin, V. Keschrumrus, and Q. Lu Cancer stem cells from a rare form of glioblastoma multiforme involving the neurogenic ventricular wall Cancer Cell Int 12 2012 41
99. F. McCaughan, J.C. Pole, A.T. Bankier, B.A. Konfortov, B. Carroll, and M. Falzon Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer Am J Respiratory Critical Care Med 182 2010 83 91
100. P. Yuan, H. Kadara, C. Behrens, X. Tang, D. Woods, and L.M. Solis Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung PloS one 5 2010 e9112
101. S.S. Baxi, L.C. Pinheiro, S.M. Patil, D.G. Pfister, K.C. Oeffinger, and E.B. Elkin Causes of death in long-term survivors of head and neck cancer Cancer 120 2014 1507 1513
102. E.M. Sturgis, and R.H. Miller Second primary malignancies in the head and neck cancer patient Annals Otol, Rhinol, Laryngol 104 1995 946 954
103. X. Leon, M. Del Prado Venegas, C. Orus, K. Kolanczak, J. Garcia, and M. Quer Metachronous second primary tumours in the aerodigestive tract in patients with early stage head and neck squamous cell carcinomas Euro Arch Oto-rhino-laryngology: Official J Euro Feder Oto-Rhino-Laryngol Soc 262 2005 905 909
104. W. Smith, and N. Saba Retinoids as chemoprevention for head and neck cancer: where do we go from here? Critical Rev Oncol/Hematol 55 2005 143 152